Business Wire

DAHUA-TECHNOLOGY

13.12.2021 14:47:04 CET | Business Wire | Press release

Share
Mitigating Traffic Congestion and Accidents Using Dahua Smart Traffic Management Solution

With rapid global urbanization and seemingly perpetual increase in vehicle ownership every year, improving traffic safety and efficiency has become a tough challenge. According to the assessment of international ITS organizations, an effective intelligent transportation system can help reduce traffic congestion and accidents by 20% and traffic delays by 25%. The Dahua Smart Traffic Management Solution , for example, has been applied in various countries to alleviate traffic problems and provide better driving and commuting experience. Equipped with AI, ANPR, image fusion, AR and robust communication technologies, the Dahua Smart Traffic Management Solution can accurately detect traffic violations and optimize signal control timing based on real-time data.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211213005357/en/

Traffic enforcement is one of the key focuses of this solution. By deploying traffic cameras with ANPR (e.g. ITC952-AU3F-LZF1640 model), traffic violations such as overspeeding, distracted driving, red light violation, unfastened seatbelt, illegal lane changing, etc. can be accurately detected. It supports recognition of number plates from 100 countries and allows algorithm integration with multiple countries. In addition, this Dahua solution also offers an AR Panoramic Platform that is connected to all frontend devices, and presents new labeling display system. It enables traffic operators to respond to traffic alerts and situations in time.

Another aspect of this solution involves signal control timing optimization based on real-time traffic flow . Powered by a lane-level traffic flow detection system, this solution can cover large scenes to detect multiple parameters such as lane flow, occupancy rate, queue length, traffic density, etc. With real-time data captured and analyzed, the traffic lights will automatically switch based on the time of the day and actual road traffic conditions, effectively mitigating urban traffic congestions. Green wave can be carried out during certain times for quick passage of vehicles. Also, these collected traffic data can help city operators in optimizing road network planning.

Meeting the numerous requirements of present-day traffic management, this solution has been applied in various countries and regions around the globe, including Serbia, Mongolia, Indonesia, and Saudi Arabia. One notable example of its effective implementation is in a country in Central Asia. It was deployed at an intersection where vehicle traffic reaches 170,000-250,000 cars per day. It significantly reduced waiting time, improved traffic efficiency by about 25%, helped enhance traffic flow, and lessened the effects of traffic congestion in the surrounding areas of the intersection.

Link:

ClickThru

Social Media:

https://www.facebook.com/DahuaHQ

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin6.8.2026 12:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today it is working with the U.S. Department of Verterans Affairs (VA) on a multi-site randomized controlled clinical trial. The study will evaluate the safety and efficacy of COMP360 psilocybin in the treatment of treatment-resistant depression (TRD) in veterans, including those with concurrent post-traumatic stress disorder (PTSD). The trial, titled "Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression," or PIVOT, reflects VA’s commitment to pursuing innovative solutions for veterans who have not responded to existing treatments. Compass will donate the study drug - COMP360, a synthetic, proprietary pharmaceutical-grade formulation of psilocybin optimized for stability and purity. Compass will support the education and training of the investigators and their training team through the provision of training

Great Britain Leads Europe’s FMCG Inflation as NIQ Launches New Inflation Barometer6.8.2026 09:00:00 CEST | Press release

NIQ (NYSE: NIQ) today launches its new EU5 FMCG Inflation Barometer - a monthly tracker across five Western Europe markets – France, Great Britain, Germany, Italy and Spain – designed to help retailers, manufacturers and the media understand how inflation is evolving across Europe’s largest grocery markets and how shoppers are responding. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806579111/en/ EU5 CPG Inflation slows to +1.1% The first edition of the Barometer reveals that while inflation across Europe’s FMCG sector remains relatively contained overall, significant differences persist between countries. Key findings include: Great Britain recorded the highest FMCG inflation across the EU5 at +2.3%1, above the European average of +1.1%. France and Italy reported the lowest inflation at -0.4% and +0.6% retrospectively, highlighting the uneven inflationary landscape across Europe's major economies. The monthly Barometer

NTT DOCOMO BUSINESS and Chile’s State-owned Copper Company CODELCO Launch a Study and Proof of Concept Aimed at Improving the Efficiency of Remote Copper Mine Operations Using IOWN® APN6.8.2026 06:30:00 CEST | Press release

NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation) has launched a study and proof of concept jointly with Corporación Nacional del Cobre de Chile (CODELCO) to progress remote operations at CODELCO’s copper mines using an IOWN® All-Photonics Network (APN).1 This initiative is part of a research project commissioned by Japan’s Ministry of Internal Affairs and Communications.2 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806845222/en/ Conceptual Diagram of the Demonstration To address operational challenges faced by CODELCO’s copper mines, the initiative will connect a copper mine and a remote operations center—approximately 1,500 km apart—via an IOWN APN. It will assess the feasibility of remotely operating heavy machinery using high-capacity, low-latency communication links, enhancing monitoring operations through high-definition video, and implementing a remote operations model. 1. Background Chile is o

FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release

Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release

Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye